Martin Klein

Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)

Reijneveld, J. C., Machingura, A., Coens, C., Taphoorn, M. J. B., Taal, W., Clement, P. M., Idbaih, A., de Vos, F. Y. F., Klein, M., Wick, W., Mulholland, P. J., Lewis, J., Golfinopoulos, V., Ghislain, I., Bottomley, A. & van den Bent, M. J., 1 Sept 2023, In: European Journal of Cancer. 190, 112946.

Research output: Contribution to journal › Article › Academic › peer-review

Cognitive outcomes after multimodal treatment in adult glioma patients: A meta-analysis

de Roeck, L., Gillebert, C. L. R., van Aert, R. C. M., Vanmeenen, A., Klein, M., Taphoorn, M. J. B., Gehring, K., Lambrecht, M. & Sleurs, C., 1 Aug 2023, In: Neuro-oncology. 25, 8, p. 1395-1414 20 p.

Research output: Contribution to journal › Review article › Academic › peer-review

A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort

van Dam, M., de Jong, B. A., Willemse, E. A. J., Nauta, I. M., Huiskamp, M., Klein, M., Moraal, B., de Geus-Driessen, S., Geurts, J. J. G., Uitdehaag, B. M. J., Teunissen, C. E. & Hulst, H. E., Aug 2023, In: Journal of neurology. 270, 8, p. 3851-3861 11 p.